Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

1.0K
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.0K
Protein Import into the Peroxisomes01:27

Protein Import into the Peroxisomes

5.7K
Cells contain membrane-bound organelles called peroxisomes that oxidize organic molecules by transferring hydrogen atoms to oxygen, producing hydrogen peroxide. Peroxisomes enzymatically convert the released hydrogen peroxide into water and oxygen.
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
5.7K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

352
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
352
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

4.8K
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
4.8K
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

4.6K
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
4.6K
Overview of Metabolism01:40

Overview of Metabolism

41.3K
Living cells constantly carry out various chemical reactions which are necessary for their proper functioning. These reactions are interlinked to one another via multiple pathways. The collection of these chemical reactions is known as metabolism.
Plant Metabolism
Sunlight, the primary source of energy in plants, is first absorbed by the chlorophyll pigments present in their leaves. Plants then use this energy to carry out photosynthesis, where water is oxidized into oxygen and carbon dioxide...
41.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A retrospective cross-sectional study on newborn screening and prevalence of disorders among UAE population.

Frontiers in pediatrics·2026
Same author

Molecular dynamics simulation of GJC2 mutants reveal pathogenic mechanisms of PMLD1 and SPG44.

The Journal of general physiology·2025
Same author

Biallelic LGI1 and ADAM23 variants cause hippocampal epileptic encephalopathy via the LGI1-ADAM22/23 pathway.

Brain : a journal of neurology·2025
Same author

Molecular and clinical aspects of histone-related disorders.

Human genomics·2025
Same author

FBXO22 deficiency defines a pleiotropic syndrome of growth restriction and multi-system anomalies associated with a unique epigenetic signature.

American journal of human genetics·2025
Same author

The utility of exome sequencing in diagnosing pediatric neurodevelopmental disorders in a highly consanguineous population.

Clinical genetics·2024

Related Experiment Video

Updated: Apr 11, 2026

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure
09:28

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure

Published on: June 25, 2010

13.7K

Inborn errors of metabolism.

Ayman W El-Hattab1

  • 1Division of Clinical Genetics and Metabolic Disorders, Pediatric Department, Tawam Hospital, P.O. Box 15258, Al-Ain, United Arab Emirates.

Clinics in Perinatology
|June 5, 2015
PubMed
Summary
This summary is machine-generated.

Inborn errors of metabolism (IEM) are rare individually but common collectively. Early diagnosis and treatment in neonates are crucial to prevent severe complications and death.

Keywords:
AcidosisFatty acid oxidationHyperammonemiaHypoglycemiaMetabolicOrganic acidemiaUrea cycle

More Related Videos

Biochemical Measurement of Neonatal Hypoxia
13:13

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

14.5K
Stable Isotope In-Vivo Labeling for Mass-Spectrometry Identification of Paternal Metabolites Transferred from Sperm to Oocyte During Fertilization
05:55

Stable Isotope In-Vivo Labeling for Mass-Spectrometry Identification of Paternal Metabolites Transferred from Sperm to Oocyte During Fertilization

Published on: June 17, 2025

979

Related Experiment Videos

Last Updated: Apr 11, 2026

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure
09:28

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure

Published on: June 25, 2010

13.7K
Biochemical Measurement of Neonatal Hypoxia
13:13

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

14.5K
Stable Isotope In-Vivo Labeling for Mass-Spectrometry Identification of Paternal Metabolites Transferred from Sperm to Oocyte During Fertilization
05:55

Stable Isotope In-Vivo Labeling for Mass-Spectrometry Identification of Paternal Metabolites Transferred from Sperm to Oocyte During Fertilization

Published on: June 17, 2025

979

Area of Science:

  • Biochemistry
  • Neonatal Medicine
  • Genetics

Background:

  • Inborn errors of metabolism (IEM) represent a group of genetic disorders that are individually rare but collectively significant in the pediatric population.
  • A notable proportion of IEMs, approximately 25%, present with clinical manifestations during the neonatal period.
  • Neonates affected by IEMs often appear healthy at birth, developing nonspecific symptoms within hours or days.

Purpose of the Study:

  • To emphasize the critical importance of early identification of inborn errors of metabolism in neonates.
  • To highlight the necessity of a high index of suspicion among healthcare providers for timely diagnosis.
  • To underscore the mandatory nature of prompt therapeutic interventions for preventing mortality and morbidity.

Main Methods:

  • Clinical observation and case review of neonatal presentations of IEMs.
  • Analysis of diagnostic challenges posed by nonspecific symptoms in neonates.
  • Review of established and emerging therapeutic strategies for IEMs.

Main Results:

  • Nonspecific signs in neonates can mask serious underlying metabolic disorders.
  • Delayed diagnosis of IEMs in the neonatal period is associated with increased risk of death and severe complications.
  • Prompt and accurate diagnosis facilitates the initiation of life-saving and complication-mitigating therapies.

Conclusions:

  • A high index of suspicion for IEMs is paramount in neonatal care.
  • Early diagnosis and intervention are essential to improve outcomes for neonates with inborn errors of metabolism.
  • Effective management of IEMs requires a multidisciplinary approach involving geneticists, neonatologists, and metabolic specialists.